Hangzhou Wensli Silk Culture
301066
Yoantion Industrial Inc.,
301053
Xinlei Compressor
301317
4
QIFENG
873169
5
LAISAI LASER
871263
US Stock MarketDetailed Quotes
LYRA Lyra Therapeutics
- 0.0982
- +0.0038+4.03%
Close May 9 16:00 ET
- 0.0950
- -0.0032-3.26%
Post 20:01 ET
6.51MMarket Cap-0.08P/E (TTM)
0.1014High0.0944Low1.23MVolume0.0965Open0.0944Pre Close119.94KTurnover2.61%Turnover RatioLossP/E (Static)66.27MShares0.418552wk High1.69P/B4.62MFloat Cap0.082052wk Low--Dividend TTM47.01MShs Float22.0000Historical High--Div YieldTTM7.42%Amplitude0.0820Historical Low0.0970Avg Price1Lot Size
Lyra Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -65.60%183K | -1.54%1.53M | 43.15%209K | -64.15%195K | 30.57%598K | 29.76%532K | 14.31%1.56M | 1,227.27%146K | 51.53%544K | -12.76%458K |
| Operating revenue | -65.60%183K | -1.54%1.53M | 43.15%209K | -64.15%195K | 30.57%598K | 29.76%532K | 14.31%1.56M | 1,227.27%146K | 51.53%544K | -12.76%458K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -66.17%8.14M | -7.18%62.27M | -39.99%9.98M | -43.39%9.83M | 19.74%18.4M | 35.73%24.06M | 19.05%67.09M | 20.02%16.62M | 14.40%17.37M | 2.97%15.37M |
| Selling and administrative expenses | -43.92%3.26M | -2.92%18.5M | -17.08%3.61M | -21.43%3.93M | 12.45%5.14M | 13.48%5.82M | 8.55%19.06M | -0.95%4.36M | -2.61%5M | 10.60%4.57M |
| -General and administrative expense | -43.92%3.26M | -2.92%18.5M | -17.08%3.61M | -21.43%3.93M | 12.45%5.14M | 13.48%5.82M | 8.55%19.06M | -0.95%4.36M | -2.61%5M | 10.60%4.57M |
| Research and development costs | -73.26%4.88M | -8.88%43.77M | -48.13%6.36M | -52.28%5.9M | 22.83%13.26M | 44.79%18.24M | 23.80%48.03M | 29.79%12.27M | 23.09%12.37M | 0.06%10.8M |
| Operating profit | 66.18%-7.96M | 7.32%-60.73M | 40.73%-9.77M | 42.72%-9.64M | -19.41%-17.81M | -35.87%-23.52M | -19.16%-65.53M | -19.06%-16.48M | -13.50%-16.83M | -3.55%-14.91M |
| Net non-operating interest income expense | -72.56%298K | -34.39%2.95M | -67.49%435K | -51.68%576K | -4.68%855K | 1.31%1.09M | 332.18%4.5M | 43.41%1.34M | 1,886.67%1.19M | 2,538.24%897K |
| Non-operating interest income | -72.56%298K | -34.39%2.95M | -67.49%435K | -51.68%576K | -4.68%855K | 1.31%1.09M | 332.18%4.5M | 43.41%1.34M | 1,886.67%1.19M | 2,538.24%897K |
| Other net income (expense) | -885K | -2,137.12%-35.62M | -1.64M | -2.8M | -1,857.85%-31.17M | -20.97%-1.59M | 0 | -1.59M | ||
| Special income (charges) | ---885K | -2,137.12%-35.62M | ---1.64M | ---2.8M | -1,857.85%-31.17M | --0 | -20.97%-1.59M | --0 | --0 | ---1.59M |
| -Less：Restructuring and merger&acquisition | --885K | --10.9M | --1.64M | --2.8M | --6.45M | --0 | --0 | --0 | --0 | --0 |
| -Less:Impairment of capital assets | ---- | 1,452.70%24.72M | --0 | --0 | 1,452.70%24.72M | ---- | 20.97%1.59M | --0 | --0 | --1.59M |
| Income before tax | 61.93%-8.54M | -49.14%-93.4M | 27.52%-10.97M | 24.11%-11.87M | -208.34%-48.12M | -38.16%-22.44M | -13.31%-62.62M | -6.45%-15.14M | -5.89%-15.64M | -8.63%-15.61M |
| Income tax | -71.43%4K | -33.90%39K | -64.71%6K | -56.25%7K | 0.00%12K | 0.00%14K | 353.85%59K | 30.77%17K | 16K | 12K |
| Net income | 61.93%-8.55M | -49.07%-93.44M | 27.56%-10.98M | 24.14%-11.87M | -208.18%-48.13M | -38.12%-22.45M | -13.39%-62.68M | -6.47%-15.16M | -5.99%-15.65M | -8.72%-15.62M |
| Net income continuous Operations | 61.93%-8.55M | -49.07%-93.44M | 27.56%-10.98M | 24.14%-11.87M | -208.18%-48.13M | -38.12%-22.45M | -13.39%-62.68M | -6.47%-15.16M | -5.99%-15.65M | -8.72%-15.62M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 61.93%-8.55M | -49.07%-93.44M | 27.56%-10.98M | 24.14%-11.87M | -208.18%-48.13M | -38.12%-22.45M | -13.39%-62.68M | -6.47%-15.16M | -5.99%-15.65M | -8.72%-15.62M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 61.93%-8.55M | -49.07%-93.44M | 27.56%-10.98M | 24.14%-11.87M | -208.18%-48.13M | -38.12%-22.45M | -13.39%-62.68M | -6.47%-15.16M | -5.99%-15.65M | -8.72%-15.62M |
| Basic earnings per share | 62.86%-0.13 | -13.49%-1.43 | 27.27%-0.16 | 33.33%-0.18 | -105.56%-0.74 | 20.45%-0.35 | 31.15%-1.26 | 38.89%-0.22 | 32.50%-0.27 | 14.29%-0.36 |
| Diluted earnings per share | 62.86%-0.13 | -13.49%-1.43 | 27.27%-0.16 | 33.33%-0.18 | -105.56%-0.74 | 20.45%-0.35 | 31.15%-1.26 | 38.89%-0.22 | 32.50%-0.27 | 14.29%-0.36 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Market Insights
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025